Hls Therapeutics (TSE:HLS) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
HLS Therapeutics Inc. is set to release its first-quarter financial results for fiscal year 2024 on May 9, with a conference call scheduled for that morning. Investors and interested parties can join the call via webcast or traditional phone lines, with a taped replay available for two weeks following the event. HLS specializes in acquiring and commercializing pharmaceuticals for psychiatric and cardiovascular diseases in North American markets.
For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.